147 related articles for article (PubMed ID: 33983074)
1. Iturin: cyclic lipopeptide with multifunction biological potential.
Wan C; Fan X; Lou Z; Wang H; Olatunde A; Rengasamy KRR
Crit Rev Food Sci Nutr; 2022; 62(29):7976-7988. PubMed ID: 33983074
[TBL] [Abstract][Full Text] [Related]
2. Iturins, a special class of pore-forming lipopeptides: biological and physicochemical properties.
Maget-Dana R; Peypoux F
Toxicology; 1994 Feb; 87(1-3):151-74. PubMed ID: 8160184
[TBL] [Abstract][Full Text] [Related]
3. Structural and Functional Insights into Iturin W, a Novel Lipopeptide Produced by the Deep-Sea Bacterium
Zhou S; Liu G; Zheng R; Sun C; Wu S
Appl Environ Microbiol; 2020 Oct; 86(21):. PubMed ID: 32859591
[TBL] [Abstract][Full Text] [Related]
4. The iturin-like lipopeptides are essential components in the biological control arsenal of Bacillus subtilis against bacterial diseases of cucurbits.
Zeriouh H; Romero D; Garcia-Gutierrez L; Cazorla FM; de Vicente A; Perez-Garcia A
Mol Plant Microbe Interact; 2011 Dec; 24(12):1540-52. PubMed ID: 22066902
[TBL] [Abstract][Full Text] [Related]
5. New Cyclic Lipopeptides of the Iturin Class Produced by Saltern-Derived Bacillus sp. KCB14S006.
Son S; Ko SK; Jang M; Kim JW; Kim GS; Lee JK; Jeon ES; Futamura Y; Ryoo IJ; Lee JS; Oh H; Hong YS; Kim BY; Takahashi S; Osada H; Jang JH; Ahn JS
Mar Drugs; 2016 Apr; 14(4):. PubMed ID: 27049393
[TBL] [Abstract][Full Text] [Related]
6. Iturin: A Promising Cyclic Lipopeptide with Diverse Applications.
Yaraguppi DA; Bagewadi ZK; Patil NR; Mantri N
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892197
[TBL] [Abstract][Full Text] [Related]
7. Diversity among microbial cyclic lipopeptides: iturins and surfactins. Activity-structure relationships to design new bioactive agents.
Bonmatin JM; Laprévote O; Peypoux F
Comb Chem High Throughput Screen; 2003 Sep; 6(6):541-56. PubMed ID: 14529379
[TBL] [Abstract][Full Text] [Related]
8. Production and identification of iturin A lipopeptide from Bacillus methyltrophicus TEB1 for control of Phoma tracheiphila.
Kalai-Grami L; Karkouch I; Naili O; Slimene IB; Elkahoui S; Zekri RB; Touati I; Mnari-Hattab M; Hajlaoui MR; Limam F
J Basic Microbiol; 2016 Aug; 56(8):864-71. PubMed ID: 27125201
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Iturin V, a Novel Antimicrobial Lipopeptide from a Potential Probiotic Strain Lactobacillus sp. M31.
Singh SS; Akhtar MN; Sharma D; Mandal SM; Korpole S
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1766-1779. PubMed ID: 33987819
[TBL] [Abstract][Full Text] [Related]
10. Enhanced production of antifungal lipopeptide iturin A by Bacillus amyloliquefaciens LL3 through metabolic engineering and culture conditions optimization.
Dang Y; Zhao F; Liu X; Fan X; Huang R; Gao W; Wang S; Yang C
Microb Cell Fact; 2019 Apr; 18(1):68. PubMed ID: 30971238
[TBL] [Abstract][Full Text] [Related]
11. Lipopeptides as the antifungal and antibacterial agents: applications in food safety and therapeutics.
Meena KR; Kanwar SS
Biomed Res Int; 2015; 2015():473050. PubMed ID: 25632392
[TBL] [Abstract][Full Text] [Related]
12. Surfactin/iturin A interactions may explain the synergistic effect of surfactin on the biological properties of iturin A.
Maget-Dana R; Thimon L; Peypoux F; Ptak M
Biochimie; 1992 Dec; 74(12):1047-51. PubMed ID: 1292612
[TBL] [Abstract][Full Text] [Related]
13. Coproduction of surfactin and iturin A, lipopeptides with surfactant and antifungal properties, by Bacillus subtilis.
Sandrin C; Peypoux F; Michel G
Biotechnol Appl Biochem; 1990 Aug; 12(4):370-5. PubMed ID: 2119191
[TBL] [Abstract][Full Text] [Related]
14. Studies on lipopeptide biosynthesis by Bacillus subtilis: isolation and characterization of iturin-, surfactin+ mutants.
Feignier C; Besson F; Michel G
FEMS Microbiol Lett; 1995 Mar; 127(1-2):11-5. PubMed ID: 7737471
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of new iturins: iturin D and iturin E.
Besson F; Michel G
J Antibiot (Tokyo); 1987 Apr; 40(4):437-42. PubMed ID: 3583913
[TBL] [Abstract][Full Text] [Related]
16. Biological activity of lipopeptides from Bacillus.
Zhao H; Shao D; Jiang C; Shi J; Li Q; Huang Q; Rajoka MSR; Yang H; Jin M
Appl Microbiol Biotechnol; 2017 Aug; 101(15):5951-5960. PubMed ID: 28685194
[TBL] [Abstract][Full Text] [Related]
17. Effect-directed screening of Bacillus lipopeptide extracts via hyphenated high-performance thin-layer chromatography.
Jamshidi-Aidji M; Dimkić I; Ristivojević P; Stanković S; Morlock GE
J Chromatogr A; 2019 Nov; 1605():460366. PubMed ID: 31378526
[TBL] [Abstract][Full Text] [Related]
18. Molecular and biochemical approaches for characterization of antifungal trait of a potent biocontrol agent Bacillus subtilis RP24.
Grover M; Nain L; Singh SB; Saxena AK
Curr Microbiol; 2010 Feb; 60(2):99-106. PubMed ID: 19777301
[TBL] [Abstract][Full Text] [Related]
19. The plant-associated Bacillus amyloliquefaciens strains MEP2 18 and ARP2 3 capable of producing the cyclic lipopeptides iturin or surfactin and fengycin are effective in biocontrol of sclerotinia stem rot disease.
Alvarez F; Castro M; Príncipe A; Borioli G; Fischer S; Mori G; Jofré E
J Appl Microbiol; 2012 Jan; 112(1):159-74. PubMed ID: 22017648
[TBL] [Abstract][Full Text] [Related]
20. A biophysical study of the interaction of the lipopeptide antibiotic iturin A with aqueous phospholipid bilayers.
Grau A; Ortiz A; de Godos A; Gómez-Fernández JC
Arch Biochem Biophys; 2000 May; 377(2):315-23. PubMed ID: 10845709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
